UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 22, 2 018

 

TWINLAB CONSOLIDATED HOLDINGS, INC.
(Exact name of registrant as specified in its charter)

 

 

Nevada 001-55181 46-3951742

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

4800 T-Rex Avenue, Suite 305, Boca Raton, Florida      33431
(Address of principal executive offices) (Zip Code)

         

Registrant's telephone number, including area code (561) 443-5301

 

N/A
(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

Section 1 – Registrant’s Business and Operations

 

Item 1.01. Entry into a Material Definitive Agreement.

 

Midcap Funding X Trust

 

Midcap Funding X Trust

 

As previously reported by Twinlab Consolidated Holdings, Inc. (the “Company”) in the Company's (i) Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on January 28, 2015, (ii) Current Report on Form 8-K filed with the SEC on February 9, 2015, (iii) Current Report on Form 8-K filed with the SEC on May 6, 2015, (iv) Current Report on Form 8-K filed with the SEC on July 7, 2015, (v) Current Report on Form 8-K filed with the SEC on September 15, 2015, (vi) Current Report on Form 8-K filed with SEC on October 8, 2015, (vii) Current Report on Form 8-K filed with the SEC on February 3, 2016, (viii) Current Report on Form 8-K filed with the SEC on April 11, 2016, and (ix) Current Report on Form 8-K filed with the SEC on August 16, 2016, the Company and its direct and indirect wholly owned subsidiaries, Twinlab Consolidation Corporation ("TCC"), Twinlab Holdings, Inc. ("THI"), Twinlab Corporation ("Twinlab"), ISI Brands Inc. ("ISI"), NutraScience Labs, Inc. ("NSL"), NutraScience Labs IP Corporation ("NSLIP"), Organic Holdings LLC ("Organic"), Reserve Life Organics, LLC ("Reserve"), Resvitale, LLC ("Resvitale"), Re-Body, LLC ("Re-Body"), Innovitamin Organics, LLC ("Innovitamin"), Organics Management LLC ("Organics Mgmt."), Cocoawell, LLC ("Cocoawell"), Fembody, LLC ("Fembody"), Reserve Life Nutrition, L.L.C. ("Reserve Life"), Innovita Speciality Distribution, LLC ("Innovita") and Joie Essance, LLC ("Joie" and with the Company, TCC, THI, Twinlab, ISI, NSL, NSLIP, Organic, Reserve, Resvitale, Re-Body, Innovitamin, Organics Mgmt., Cocoawell, Fembody, Reserve Life and Innovita, collectively, the "Twinlab Companies"), entered into a Credit and Security Agreement, dated January 22, 2015, with MidCap Financial Trust ("MidCap Trust"), with respect to which Credit and Security Agreement and all related agreements MidCap Trust immediately thereafter assigned all of its rights and interests to MidCap Funding X Trust ("MidCap"), an affiliate of MidCap Trust (as so assigned and subsequently amended by that certain Amendment No. 1 to Credit and Security Agreement and Limited Consent, dated as of February 4, 2015, that certain Amendment No. 2 to Credit Agreement and Limited Consent dated as of April 7, 2015, that certain Amendment No. 3 to Credit and Security Agreement and Limited Consent dated as of April 30, 2015, that certain Amendment No. 4 to Credit and Security Agreement and Limited Waiver dated as of June 30, 2015, that certain Amendment No. 5 to Credit and Security Agreement and Limited Consent, dated as of June 30, 2015, that certain Amendment No. 6 to Credit and Security Agreement, Limited Consent and Limited Waiver dated as of September 9, 2015, that certain Amendment No. 7 and Joinder Agreement to Credit and Security Agreement dated as of October 5, 2015, that certain Amendment No. 8 to Credit and Security Agreement dated as of January 28, 2016, that certain Amendment No. 9, dated as of April 5, 2016, Amendment No. 10 dated as of August 11, 2016, Amendment No. 11 dated as of September 1, 2016, Amendment No. 12 dated as of December 2, 2016, and Amendment No. 13 dated as of August 30, 2017 (the "Credit Agreement").

 

On March 22, 2018, the Twinlab Companies and MidCap entered into Amendment No. 14 to Credit and Security Agreement and Limited Waiver (the "MidCap Fourteenth Amendment"). Pursuant to the MidCap Fourteenth Amendment, MidCap granted a waiver with respect to the Twinlab Companies' failure to sa tisfy Section 6.2 (Minimum Adjusted EBITDA) of the Credit Agreement because Twinlab Companies’ Adjusted EBITDA was less than $-1,900,000 with respect to the measurement period from January 1, 2017 to December 31, 2017. The waiver is limited to the measurement periods from April 1, 2017 to March 31, 2018 and from July 1, 2017 to June 30, 2018. The MidCap Fourteenth Amendment also added or amended certain defined terms and reduced the required minimum liquidity to $1,000,000 or greater commencing February 6, 2018.

 

The foregoing description of the MidCap Fourteenth Amendment is qualified in its entirety by reference to the full text of such document, which document is an exhibit to this Report.

 

 

 

 

Section 2 – Financial Information

 

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth in Item 1.01 regarding the MidCap Fourteenth Amendment is hereby incorporated by reference into this Item 2.03.

 

Section 9 – Financial Statements and Exhibits

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.     Description
     
10. 174   Amendment No. 14 to Credit and Security Agreement and Limited Waiver, dated as of March 22, 2018, by and among Twinlab Consolidated Holdings, Inc., Twinlab Consolidation Corporation, Twinlab Holdings, Inc., ISI Brands Inc., Twinlab Corporation, NutraScience Labs, Inc., NutraScience Labs IP Corporation, Organic Holdings LLC, Reserve Life Organics, LLC, Resvitale, LLC, Re-Body, LLC, Innovitamin Organics, LLC, Organics Management LLC, Cocoawell, LLC, Fembody, LLC, Reserve Life Nutrition, L.L.C., Innovita Specialty Distribution, LLC, Joie Essance, LLC and MidCap Funding X Trust.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  TWINLAB CONSOLIDATED HOLDINGS, INC.
     
     
     
     
Date: March 28, 2018 By: /s/ Naomi L. Whittel
   

Naomi L. Whittel

Chief Executive Officer

 

Exhibit 10.174

 

AMENDMENT NO. 14 TO CREDIT AND SECURITY AGREEMENT  

AND LIMITED WAIVER

 

THIS AMENDMENT NO. 14 TO CREDIT AND SECURITY AGREEMENT AND LIMITED WAIVER (this “ Amendment ”) is made as of this ___ day of March, 2018, by and among TWINLAB CONSOLIDATED HOLDINGS, INC. , a Nevada corporation, TWINLAB CONSOLIDATION CORPORATION , a Delaware corporation, TWINLAB HOLDINGS, INC. , a Michigan corporation, ISI BRANDS INC. , a Michigan corporation, TWINLAB CORPORATION , a Delaware corporation, NUTRASCIENCE LABS, INC. , a Delaware corporation (formerly known as TCC CM Subco I, Inc.), NUTRASCIENCE LABS IP CORPORATION , a Delaware corporation (formerly known as TCC CM Subco II, Inc.), ORGANIC HOLDINGS LLC , a Delaware limited liability company, RESERVE LIFE ORGANICS, LLC , a Delaware limited liability company, RESVITALE, LLC , a Delaware limited liability company, RE-BODY, LLC , a Delaware limited liability company, INNOVITAMIN ORGANICS, LLC , a Delaware limited liability company, ORGANICS MANAGEMENT LLC , a Delaware limited liability company, COCOAWELL, LLC , a Delaware limited liability company, FEMBODY, LLC , a Delaware limited liability company, RESERVE LIFE NUTRITION, L.L.C. , a Delaware limited liability company, INNOVITA SPECIALTY DISTRIBUTION, LLC , a Delaware limited liability company, and JOIE ESSANCE, LLC , a Delaware limited liability company (each of the foregoing Persons being referred to herein individually as a “ Borrower ”, and collectively as “ Borrowers ”), and MIDCAP FUNDING X TRUST, a Delaware statutory trust, as successor-by-assignment from MidCap Financial Trust (as Agent for Lenders, “ Agent ”, and individually, as a Lender), and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.

 

RECITALS

 

A.      Pursuant to that certain Credit and Security Agreement dated as of January 22, 2015 by and among Borrowers, Agent and Lenders (as amended by that certain Amendment No. 1 to Credit and Security Agreement and Limited Consent dated as of February 4, 2015, by that certain Amendment No. 2 to Credit and Security Agreement and Limited Consent dated as of April 7, 2015, by that certain Amendment No. 3 to Credit and Security Agreement and Limited Consent dated as of April 30, 2015, by that certain Amendment No. 4 to Credit and Security Agreement and Limited Waiver dated as of June 30, 2015, by that certain Amendment No. 5 to Credit and Security Agreement and Limited Consent dated as of June 30, 2015, by that certain Amendment No. 6 to Credit and Security Agreement, Limited Consent and Limited Waiver dated as of September 9, 2015, by that certain Amendment No. 7 and Joinder Agreement to Credit and Security Agreement dated as of October 5, 2015, by that certain Amendment No. 8 to Credit and Security Agreement dated as of January 28, 2016, by that certain Amendment No. 9 to Credit and Security Agreement dated as of April 5, 2016, by that certain Amendment No. 10 to Credit and Security Agreement dated as of August 11, 2016, but effective as of July 29, 2016, by that certain Amendment No. 11 to Credit and Security Agreement dated as of September 1, 2016, by that certain Amendment No. 12 to Credit and Security Agreement and Limited Consent dated as of December 2, 2017, by that certain Amendment No. 13 to Credit and Security Agreement and Limited Consent dated as of August 30, 2017 and as it may be further amended, modified and restated from time to time, the “ Credit Agreement ”), Agent and Lenders agreed to make available to Borrowers a secured revolving credit facility in a principal amount of up to $17,000,000 from time to time (as amended, modified, supplemented, extended and restated from time to time, collectively, the “ Loans ”). Capitalized terms used but not otherwise defined in this Amendment shall have the meanings set forth in the Credit Agreement.

 

 

 

 

B.       Borrowers have failed to satisfy Section 6.2 (Minimum Adjusted EBITDA) of the Credit Agreement because Borrowers’ Adjusted EBITDA was less than $-1,900,000 with respect to the measurement period from January 1, 2017 to December 31, 2017, and such failure constitutes an Event of Default under the Credit Agreement (the “ Existing Event of Default ”). Borrowers have requested that Agent and the Lenders waive the Existing Event of Default, and Agent and Lenders have agreed to do so, in accordance with the terms and subject to the conditions set forth herein .

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the foregoing, the terms and conditions set forth in this Amendment, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Agent, Lenders and Borrowers hereby agree as follows:

 

1.      Recitals. This Amendment shall constitute a Financing Document and the Recitals set forth above shall be construed as part of this Amendment as if set forth fully in the body of this Amendment.

 

2.       Amendment to Credit Agreement.      

 

 

(a)      Section 1.1 of the Credit Agreement is hereby amended to add the defined term “February 2018 Subordination Agreement (Golisano Holdings)” in its alphabetical order:

 

“February 2018 Subordination Agreement (Golisano Holdings)” means the Subordination Agreement dated as of February 6, 2018, between Agent and Golisano Holdings, and acknowledged by Borrowers, as the same may be amended, restated, amended and restated, supplemented or otherwise modified from time to time.

 

(b)       Section 1.1 – Definition of Golisano Holdings Debt . The defined term “Golisano Holdings Debt” in Section 1.1 of the Credit Agreement is hereby amended and restated in its entirety as follows:

 

Golisano Holdings Debt” means the “Subordinated Loans” (as that term is defined in the Subordination Agreement (Golisano Holdings)) and the “Subordinated Debt” (as that term is defined in the February 2018 Subordination Agreement (Golisano Holdings)) .

 

 

 

 

(c)      Section 6.4 of the Credit Agreement is hereby amended and restated in its entirety as follows:

 

Minimum Liquidity. Commencing February 6 , 201 8 and until such time as all Obligations are paid, satisfied and discharged in full, the Borrowers shall at all times, as tested as of the end of any month, have Minimum Liquidity for the test date equal to or in excess of $1,000,000 .

 

3.       Acknowledgement of Ex isting Event of Default . Prior to the effectiveness of this Amendment, the existence of the Existing Event of Default (a) relieved Agent and Lenders from any obligation to provide any financial accommodations under the Credit Agreement or other Financing Documents, and (b) permitted Agent and Lenders to, among other things, (i) accelerate all or any portion of the Obligations, (ii) commence any legal or other action to collect any or all of the Obligations from Borrowers and/or any Collateral, (iii) foreclose or otherwise realize on any or all of the Collateral, and/or appropriate, set-off and apply to the payment of any or all of the Obligations, any or all of the Collateral, and/or (iv) take any other enforcement action or otherwise exercise any or all rights and remedies provided for by any or all of the Credit Agreement, the other Financing Documents or applicable law.

 

4 .      Limited Waiver. Each of the Borrowers hereby acknowledges and agrees that the Existing Event of Default continues to exist as of the date hereof. At the request of and as an accommodation to Borrowers and subject to the terms and conditions set forth herein, Agent and Lenders hereby (i) waive the Existing Event of Default and (ii) waive compliance with and agree that compliance shall not be required with respect to Section 6.2 (Minimum Adjusted EBITDA) solely for the measurement periods from (1) April 1, 2017 to March 31, 2018 and (2) July 1, 2017 to June 30, 2018, but such financial covenant shall still be tested as of the end of each such measurement period. The limited waiver set forth in this Section 4 is effective solely for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) except as expressly provided herein, be a consent to any amendment, waiver or modification of any term or condition of the Credit Agreement or of any other Financing Document; (b) prejudice any right that Agent or the Lenders have or may have in the future under or in connection with the Credit Agreement or any other Financing Document, including, without limitation, the rights of the Agent under Section 2.1(b)(i) of the Credit Agreement; (c) waive any other Event of Default that may exist as of the date hereof; (d) waive compliance with Section 6.2 of the Credit Agreement for any period other than with respect to the measurement periods from (1) January 1, 2017 to December 31, 2017, (2) April 1, 2017 to March 31, 2018 and (3) July 1, 2017 to June 30, 2018; or (e) establish a custom or course of dealing among any of the Credit Parties, on the one hand, or Agent or any Lender, on the other hand.

 

5 .      Confirmation of Representations and Warranties; Reaffirmation of Security Interest. Each Borrower hereby (a) confirms that all of the representations and warranties set forth in the Credit Agreement are, after giving effect to this Amendment and the transactions contemplated hereby, true and correct with respect to such Borrower as of the date hereof to the same extent as though made on and as of such date, except to the extent such representations and warranties specifically relate to an earlier date, and (b) covenants to perform its respective obligations under the Credit Agreement. Each Borrower confirms and agrees that all security interests and Liens granted to Agent continue in full force and effect, and all Collateral remains free and clear of any Liens, other than those granted to Agent and Permitted Liens. Nothing herein is intended to impair or limit the validity, priority or extent of Agent’s security interests in and Liens on the Collateral.

 

 

 

 

6 .      Enforceability. This Amendment constitutes the legal, valid and binding obligation of each Borrower, and is enforceable against each of the Borrowers in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency or other similar laws relating to the enforcement of creditors’ rights generally and by general equitable principles.

 

7 .       Costs and Fees . In consideration of Agent’s and the Lenders’ agreement to enter into this Amendment, Borrower shall pay to Agent a modification fee equal to One Hundred Thousand and No/100 Dollars ($100,000.00), of which (i) Fifty Thousand and No/100 Dollars ($50,000) shall be due and payable on the date hereof, (ii) Twenty Five Thousand and No/100 Dollars ($25,000) shall be due and payable on or before May 1, 2018 and (iii) Twenty Five Thousand and No/100 Dollars ($25,000) shall be due and payable on or before June 1, 2018. Furthermore, Borrowers shall be responsible for the payment of all reasonable costs and fees of Agent’s counsel incurred in connection with the preparation of this Amendment and any related documents. If Agent or any Lender uses in-house counsel for any of these purposes, Borrowers further agree that the Obligations include reasonable charges for such work commensurate with the fees that would otherwise be charged by outside legal counsel selected by Agent or such Lender for the work performed. Borrowers hereby authorize Agent to deduct all of such fees set forth in this Section 7 from the proceeds of one or more Revolving Loans made under the Credit Agreement.

 

8 .       Conditions to Effectiveness. This Amendment shall become effective as of the date on which each of the following conditions has been satisfied (the “ Effective Date ”):

 

(a)     Borrowers shall have delivered to Agent this Amendment, duly executed by an authorized officer of each Borrower;

 

(b)      all representations and warranties of Borrowers contained herein shall be true and correct in all material respects as of the Effective Date (and such parties’ delivery of their respective signatures hereto shall be deemed to be its certification thereof); and

 

(c)     Agent shall have received from Borrowers all of the fees owing pursuant to this Amendment and Agent’s reasonable out-of-pocket legal fees and expenses.

 

9 .      Post- Fourteenth Amendment Closing Requirements . Borrowers shall complete each of the post-closing obligations and/or provide to Agent each of the documents, instruments, agreements and information listed on Schedule 7.4(C) attached hereto on or before the date set forth for each such item thereon, each of which shall be completed or provided in form and substance satisfactory to Agent.

 

10.       Release. Each Borrower, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for and on behalf of itself and all of its respective parents, subsidiaries, affiliates, members, managers, predecessors, successors, and assigns, and each of their respective current and former directors, officers, shareholders, agents, and employees (collectively, “ Releasing Parties ”), does hereby fully and completely release, acquit and forever discharge each Indemnitee of and from any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities, costs, expenses and demands of any kind whatsoever, at law or in equity, whether matured or unmatured, liquidated or unliquidated, vested or contingent, choate or inchoate, known or unknown that the Releasing Parties (or any of them) has against the Indemnitees (or any of them) that directly or indirectly arise out of, are based upon or are in any manner connected with any Prior Related Event. “ Prior Related Event ” means any transaction, event, circumstance, action, failure to act, occurrence of any type or sort, whether known or unknown, which occurred, existed, was taken, was permitted or begun in accordance with, pursuant to or by virtue of (a) any of the terms of this Amendment or any other Financing Document, (b) any actions, transactions, matters or circumstances related hereto or thereto, (c) the conduct of the relationship between any Indemnitee and any Borrower, or (d) any other actions or inactions by any Indemnitee, all on or prior to the Effective Date. Each Borrower acknowledges that the foregoing release is a material inducement to Agent’s and Lender’s decision to enter into this Amendment and to agree to the modifications contemplated hereunder.

 

 

 

 

1 1 .      No Waiver or Novation. The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided in this Amendment, operate as a waiver of any right, power or remedy of Agent, nor constitute a waiver of any provision of the Credit Agreement, the Financing Documents or any other documents, instruments and agreements executed or delivered in connection with any of the foregoing. Nothing herein is intended or shall be construed, except as expressly provided in this Amendment, as a waiver of any existing Defaults or Events of Default under the Credit Agreement or other Financing Documents or any of Agent’s rights and remedies in respect of such Defaults or Events of Default. This Amendment (together with any other document executed in connection herewith) is not intended to be, nor shall it be construed as, a novation of the Credit Agreement.

 

1 2 .       Affirmation. Except as specifically amended and waived pursuant to the terms hereof, the Credit Agreement and all other Financing Documents (and all covenants, terms, conditions and agreements therein) shall remain in full force and effect, and are hereby ratified and confirmed in all respects by Borrowers. Each Borrower covenants and agrees to comply with all of the terms, covenants and conditions of the Credit Agreement (as amended and modified hereby) and the Financing Documents, notwithstanding any prior course of conduct, waivers, releases or other actions or inactions on Agent’s or any Lender’s part which might otherwise constitute or be construed as a waiver of or amendment to such terms, covenants and conditions.

 

1 3 .      Miscellaneous.

 

(a)      Reference to the Effect on the Credit Agreement. Upon the effectiveness of this Amendment, each reference in the Credit Agreement to “this Agreement,” “hereunder,” “hereof,” “herein,” or words of similar import shall mean and be a reference to the Credit Agreement, as amended and modified by this Amendment. Except as specifically amended and waived above, the Credit Agreement, and all other Financing Documents (and all covenants, terms, conditions and agreements therein), shall remain in full force and effect, and are hereby ratified and confirmed in all respects by Borrowers.

 

(b)       Incorporation of Credit Agreement Provisions. The provisions contained in Section 11.6 (Indemnification), Section 12.8 (Governing Law; Submission to Jurisdiction) and Section 12.9 (Waiver of Jury Trial) of the Credit Agreement are incorporated herein by reference to the same extent as if reproduced herein in their entirety.

 

 

 

 

(c)      Headings. Section headings in this Amendment are included for convenience of reference only and shall not constitute a part of this Amendment for any other purpose.

 

(d)      Counterparts. This Amendment may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. Signatures by facsimile or by electronic mail delivery of an electronic version (e.g., .pdf or .tif file) of an executed signature page shall be treated as delivery of an original and shall bind the parties hereto. This Amendment constitutes the entire agreement and understanding among the parties hereto and supersede any and all prior agreements and understandings, oral or written, relating to the subject matter hereof.

 

 

[SIGNATURES APPEAR ON FOLLOWING PAGES]

 

 

 

 

( Signature Page to Amendment No. 14 to Credit and Security Agreement and Limited Waiver )

 

 

IN WITNESS WHEREOF , intending to be legally bound, and intending that this document constitute an agreement executed under seal, the undersigned have executed this Amendment under seal as of the day and year first hereinabove set forth.

 

 

AGENT: MIDCAP FUNDING X TRUST, a Delaware statutory trust, as successor-by-assignment from MidCap Financial Trust
       
  By:

Apollo Capital Management, L.P.,

its investment manager

       
  By:

Apollo Capital Management GP, LLC,

its general partner

 

 

  By: /s/ Maurice Amsellem (SEAL)
  Name: Maurice Amsellem  
  Title: Authorized Signatory  

 

 

 

LENDER:   MIDCAP FUNDING X TRUST, a Delaware statutory trust, as successor-by-assignment from MidCap Financial Trust
       
  By:

Apollo Capital Management, L.P.,

its investment manager

       
  By:

Apollo Capital Management GP, LLC,

its general partner

 

 

  By: /s/ Maurice Amsellem ( (SEAL)
  Name: Maurice Amsellem  
  Title:   Authorized Signatory  

    

 

 

 

( Signature Page to Amendment No. 14 to Credit and Security Agreement and Limited Waiver )

 

 

BORROWERS:

TWINLAB CONSOLIDATION CORPORATION

 

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Chief Executive Officer

   
   
   
TWINLAB CONSOLIDATED HOLDINGS, INC. TWINLAB HOLDINGS, INC .
   
   

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Chief Executive Officer

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Chief Executive Officer

   
   
TWINLAB CORPORATION ISI BRANDS INC.
   
   

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Chief Executive Officer

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Chief Executive Officer

   
   
NUTRASCIENCE LABS, INC. NUTRASCIENCE LABS IP CORPORATION
   
   

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Chief Executive Officer

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Chief Executive Officer

   
   
ORGANIC HOLDINGS LLC RESERVE LIFE ORGANICS, LLC
   

 

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Sole Manager

By ORGANIC HOLDINGS LLC,

its sole Member

 

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Sole Manager

 

 

 

 

( Signature Page to Amendment No. 14 to Credit and Security Agreement and Limited Waiver )

 

 

RESVITALE, LLC

 

By ORGANIC HOLDINGS LLC,

its sole Member

 

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Sole Manager  

RE-BODY, LLC

 

By ORGANIC HOLDINGS LLC,

its sole Member

 

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Sole Manager

   

INNOVITAMIN ORGANICS, LLC

 

By ORGANIC HOLDINGS LLC,

its sole Member

 

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Sole Manager

ORGANICS MANAGEMENT LLC

 

By ORGANIC HOLDINGS LLC,

its sole Member

 

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Sole Manager

   

COCOAWELL, LLC

 

By ORGANIC HOLDINGS LLC,

its sole Member

 

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Sole Manager

FEMBODY, LLC

 

By ORGANIC HOLDINGS LLC,

its sole Member

 

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Sole Manager

   

RESERVE LIFE NUTRITION, L.L.C.

 

By ORGANIC HOLDINGS LLC,

its sole Member

 

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Sole Manager  

INNOVITA SPECIALTY DISTRIBUTION, LLC

 

By ORGANIC HOLDINGS LLC,

its sole Member

 

By: /s/ Naomi Whittel                       (Seal)

Name: Naomi Whittel
Title: Sole Manager

   

JOIE ESSANCE, LLC

 

By ORGANIC HOLDINGS LLC,

its sole Member

 

By:__ /s/ Naomi Whit tel __(Seal)

Name: Naomi Whittel
Title: Sole Manager